Medicare Enrolled
Dr. Gopal Kunta, M.D.
Hematology & Oncology · Clermont, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kunta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kunta? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kunta
Dr. Gopal Kunta is a hematology & oncology in Clermont, FL, with 20 years in practice. Based on federal Medicare data, Dr. Kunta performed 274,920 Medicare services across 3,502 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kunta received a total of $43,452 from 96 pharmaceutical and/or device companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kunta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $43,452 industry payments
Medicare Practice Summary
Medicare Utilization ↗274,920
Medicare services
Top 1% in FL for hematology & oncology
3,502
Unique beneficiaries
$3
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~13,746 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 222,902 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia | 14,261 | $6 | $22 |
| Denosumab injection (Prolia/Xgeva) | 10,860 | $17 | $32 |
| Anti-nausea injection (ondansetron/Zofran) | 6,464 | $0 | $3 |
| Dexamethasone injection (steroid) | 5,312 | $0 | $1 |
| Blood draw (venipuncture) | 2,332 | $8 | $8 |
| Complete blood count (CBC) with differential | 2,287 | $8 | $27 |
| Office visit, established patient (30-39 min) | 1,503 | $98 | $268 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 1,274 | $48 | $185 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,056 | $22 | $78 |
| Injection, diphenhydramine hcl, up to 50 mg | 799 | $1 | $2 |
| Injection of additional new drug or substance into vein | 739 | $12 | $55 |
| Drug injection, under skin or into muscle | 727 | $11 | $60 |
| Administration of chemotherapy into vein, 1 hour or less | 576 | $100 | $333 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 482 | $15 | $46 |
| Injection, carboplatin, 50 mg | 453 | $2 | $9 |
| Flow cytometry, additional marker | 440 | $18 | $42 |
| Administration of chemotherapy into vein, each additional hour | 322 | $22 | $75 |
| Unclassified drugs | 312 | $1 | $7 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 246 | $97 | $312 |
| Administration of additional new drug or substance into vein, 1 hour or less | 241 | $50 | $174 |
| Injection, zoledronic acid, 1 mg | 239 | $6 | $136 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 165 | $1 | $6 |
| New patient office visit (45-59 min) | 157 | $129 | $407 |
| Injection, heparin sodium, per 1000 units | 157 | $0 | $1 |
| Office visit, established patient (20-29 min) | 149 | $68 | $182 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 105 | $16 | $54 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 105 | $26 | $80 |
| Infusion into a vein for hydration, each additional hour | 62 | $10 | $38 |
| Irrigation of implanted venous access drug delivery device | 49 | $16 | $62 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 39 | $1 | $5 |
| Drawing of blood for a medical problem | 29 | $70 | $229 |
| Infusion, normal saline solution, 250 cc | 28 | $1 | $10 |
| Flow cytometry technique for dna or cell analysis, 16 or more markers | 17 | $65 | $169 |
| Flow cytometry technique for dna or cell analysis, first marker | 16 | $55 | $131 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 15 | $132 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.1% high complexity
96.1% medium
2.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$43,452
Total received (2018-2024)
Avg $6,207/year across 7 years
Top 16% in FL for hematology & oncology
96
Companies
930
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,579 (47.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$17,039 (39.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,795 (8.7%)
Other
Charitable contributions, space rental, and other categories
$2,040 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,811
2023$6,525
2022$3,326
2021$5,013
2020$4,045
2019$14,822
2018$4,910
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$5,612
Novartis Pharmaceuticals Corporation
$4,723
Janssen Biotech, Inc.
$4,344
Takeda Pharmaceuticals U.S.A., Inc.
$2,522
Celgene Corporation
$2,266
Puma Biotechnology, Inc.
$2,008
Heron Therapeutics, Inc.
$1,638
Daiichi Sankyo Inc.
$1,525
E.R. Squibb & Sons, L.L.C.
$1,367
Secura Bio, Inc.
$1,268
PFIZER INC.
$1,166
Athenex Pharmaceutical Division, LLC
$1,000
Astellas Pharma US Inc
$999
Lilly USA, LLC
$896
ASD Specialty Healthcare, LLC
$762
Exelixis Inc.
$755
Amgen Inc.
$719
GENZYME CORPORATION
$712
Coherus Biosciences Inc.
$591
ABBVIE INC.
$571
Merck Sharp & Dohme Corporation
$470
Kite Pharma, Inc.
$452
Incyte Corporation
$405
Merck Sharp & Dohme LLC
$346
Octapharma USA, Inc.
$328
ASD SPECIALTY HEALTHCARE, LLC
$301
Karyopharm Therapeutics Inc.
$292
Bayer Healthcare Pharmaceuticals Inc.
$259
Gilead Sciences, Inc.
$243
Genentech USA, Inc.
$238
Bayer HealthCare Pharmaceuticals Inc.
$221
TAIHO ONCOLOGY, INC.
$217
Alexion Pharmaceuticals, Inc.
$214
BeiGene USA, Inc.
$207
Boehringer Ingelheim Pharmaceuticals, Inc.
$179
Eisai Inc.
$178
G1 Therapeutics, Inc.
$173
Regeneron Healthcare Solutions, Inc.
$169
NOVARTIS PHARMACEUTICALS CORPORATION
$167
GlaxoSmithKline, LLC.
$145
EAGLE PHARMACEUTICALS, INC.
$138
AbbVie, Inc.
$135
Kyowa Kirin, Inc.
$133
Pharmacyclics LLC, An AbbVie Company
$130
Intuitive Surgical, Inc.
$121
ARRAY BIOPHARMA INC
$120
Foundation Medicine, Inc.
$93
TG THERAPEUTICS, INC.
$93
TerSera Therapeutics LLC
$91
JAZZ PHARMACEUTICALS INC.
$89
SOBI, INC
$87
Global Blood Therapeutics, Inc.
$86
TOLMAR Pharmaceuticals, Inc.
$83
Verity Pharmaceuticals Inc.
$81
Janssen Scientific Affairs, LLC
$75
Myovant Sciences Inc.
$73
Sun Pharmaceutical Industries Inc.
$68
Seattle Genetics, Inc.
$68
Pharmacosmos Therapeutics Inc.
$67
Janssen Pharmaceuticals, Inc
$60
CSL Behring
$52
PUMA BIOTECHNOLOGY, INC.
$49
Seagen Inc.
$49
Taiho Oncology, Inc.
$41
Boston Scientific Corporation
$38
EISAI INC.
$38
Dova Pharmaceuticals
$37
EUSA Pharma (US) LLC
$37
Myriad Genetic Laboratories, Inc.
$36
Amneal Pharmaceuticals LLC
$36
Genmab U.S., Inc.
$35
IntrinsiQ Specialty Solutions, Inc.
$33
R-Pharm US LLC
$27
AMAG Pharmaceuticals, Inc.
$26
TESARO, Inc.
$24
Teva Pharmaceuticals USA, Inc.
$23
EMD Serono, Inc.
$21
Sumitomo Pharma America, Inc.
$20
Dendreon Pharmaceuticals LLC
$20
ACCORD HEALTHCARE, INC.
$19
PharmaEssentia USA Corporation
$19
Sandoz Inc.
$19
Partner Therapeutics, Inc.
$19
Pharmacyclics LLC, an AbbVie Company
$19
SpringWorks Therapeutics, Inc.
$18
Tolmar, Inc.
$17
Jazz Pharmaceuticals Inc.
$16
Blueprint Medicines Corporation
$16
MorphoSys, US Inc.
$16
Verastem, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$16
Grifols USA, LLC
$15
Ipsen Biopharmaceuticals, Inc
$14
Clovis Oncology, Inc.
$13
SECURA BIO, INC.
$13
MEDIVATION FIELD SOLUTIONS LLC
$9
Top 3 companies account for 33.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRACANALYSIS CDX · BRAFTOVI · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CAR-T · CINVANTI · COBENFY · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epclusa · Epkinly · Erleada · FARESTON · FARYDAK · FERAHEME · FOUNDATIONONE · FRUZAQLA · Farydak · GAZYVA · GILOTRIF · GLEEVEC · Gamunex-C · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Inrebic · Ixempra · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LOQTORZI · LUMAKRAS · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MVASI · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · PEMFEXY · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Prolia · QUZYTTIR · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SPRYCEL · SUTENT · SpaceOAR VUE System - 10mL · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TUKYSA · Tecentriq · Trelstar · Trodelvy · UKONIQ · Udenyca · VELCADE · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Venclexta · Vitrakvi · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZIEXTENZO · ZOLADEX · ZYTIGA · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (47%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $16 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
35
Per 100K population
8.8
County median income
$69,956
Nearest hospital
ORLANDO HEALTH SOUTH LAKE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kunta is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (mixed engagement, top 16%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kunta experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Kunta performed 222,902 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kunta receive payments from pharmaceutical companies?
Yes. Dr. Kunta received a total of $43,452 from 96 companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kunta's costs compare to other hematology & oncologys in Clermont?
Dr. Kunta's average Medicare payment per service is $3. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kunta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Clermont
Browse hematology & oncologys in Clermont ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology